![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Technik-/Wissenschafts-/F&E-Leiter bei
KYMERA THERAPEUTICS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Jared Gollob is Chief Medical Officer at Kymera Therapeutics, Inc. since 2018.
Formerly, Dr. Gollob was Director of the Biologic Therapy Program at Duke University from 2002 to 2007.
From 2012 to 2018, Dr. Gollob was Global VP of Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 71.359 ( 0,09 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Jared Gollob
| Unternehmen | Position | Beginn |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 |
Ehemalige bekannte Positionen von Jared Gollob
| Unternehmen | Position | Ende |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.09.2007 |
Ausbildung von Jared Gollob
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
